Equitable Holdings’s ARK Genomic Revolution ETF ARKG Stock Holding History
Bought
Maintained
Sold
Other funds holding ARKG
Equitable Holdings's ARKG Position: Q1 2026 in Review
Equitable Holdings reduced its ARK Genomic Revolution ETF (ARKG) stake by 0.58% in Q1 2026, selling an estimated $7.32K and leaving 42,876 shares worth $1.24M. The position accounts for 0.01% of the portfolio, ranked #898.
Equitable Holdings first reported a position in ARKG in Q2 2020 and has held it in 15 quarters since. The position peaked at $1.41M in Q2 2021. 218 funds tracked by Wall St. Rank hold ARKG as of Q1 2026.
- Equitable Holdings held 42,876 shares of ARK Genomic Revolution ETF worth $1.24M as of Q1 2026.
- Equitable Holdings sold 250 ARK Genomic Revolution ETF shares in Q1 2026, an estimated $7.32K.
- ARK Genomic Revolution ETF made up 0.01% of Equitable Holdings's portfolio in Q1 2026, its #898 holding.
- Equitable Holdings first reported a position in ARK Genomic Revolution ETF in Q2 2020 and has held it in 15 quarters since.
- Equitable Holdings's ARK Genomic Revolution ETF position peaked at $1.41M in Q2 2021.
- 218 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q1 2026.
Based on Equitable Holdings's 13F filing for Q1 2026, filed 15 May 2026.